EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome

Rosa Scala, Fatima Maqoud, Conor McClenaghan, Theresa M Harter, Maria Grazia Perrone iD, Antonio Scilimati iD, Colin G Nichols, Domenico Tricarico

Cells · 2023

DOI: 10.3390/cells12060928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Rosa Scala und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sections of Pharmacology, Medicinal Chemistry, Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy. Hauptthemen laut MEDLINE: Zoledronic Acid, Muscle, Skeletal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Società Italiana di Farmacologia (SIF), “Erasmus + for Traineeship” fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cantú syndrome (CS) is caused by the gain of function mutations in the ABCC9 and KCNJ8 genes encoding, respectively, for the sulfonylureas receptor type 2 (SUR2) and the inwardly rectifier potassium channel 6.1 (Kir6.1) of the ATP-sensitive potassium (KATP) channels. CS is a multi-organ condition with a cardiovascular phenotype, neuromuscular symptoms, and skeletal malformations. Glibenclamide has been proposed for use in CS, but even in animals, the drug is incompletely effective against severe mutations, including the Kir6.1wt/V65M. Patch-clamp experiments showed that zoledronic acid (ZOL) fully reduced the whole-cell KATP currents in bone calvaria cells from wild type (WT/WT) and heterozygous Kir6.1wt/V65MCS mice, with IC50 for ZOL block < 1 nM in each case. ZOL fully reduced KATP current in excised patches in skeletal muscle fibers in WT/WT and CS mice, with IC50 of 100 nM in each case. Interestingly, KATP currents in the bone of heterozygous SUR2wt/A478V mice were less sensitive to ZOL inhibition, showing an IC50 of ~500 nM and a slope of ~0.3. In homozygous SUR2A478V/A478V cells, ZOL failed to fully inhibit the KATP currents, causing only ~35% inhibition at 100 μM, but was responsive to glibenclamide. ZOL reduced the KATP currents in Kir6.1wt/VMCS mice in both skeletal muscle and bone cells but was not effective in the SUR2[A478V] mice fibers. These data indicate a subunit specificity of ZOL action that is important for appropriate CS therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidMuscle, SkeletalGlyburideKATP ChannelsOsteochondrodysplasiasHypertrichosisDisease Models, AnimalAdenosine TriphosphateOsteoblastsMiceAnimalsSulfonylurea ReceptorsCardiomegaly

Stichwörter der Autor:innen

ATP-sensitive potassium channelCantú syndromeanti-cancer drugglibenclamidepatch clamprare diseaseskeletal musclezoledronic acid

Substanzen

Adenosine TriphosphateGlyburideZoledronic AciduK-ATP-1 potassium channelKATP ChannelsAbcc9 protein, mouseSulfonylurea Receptors

Autor:innen und Institutionen

  • Sections of Pharmacology, Medicinal Chemistry, Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
  • Center for the Investigation of Membrane Excitability Diseases, Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110-1010, USA.

ORCID-Profile: Maria Grazia Perrone, Antonio Scilimati

Förderung

  • NHLBI NIH HHS
  • Società Italiana di Farmacologia (SIF)
  • “Erasmus + for Traineeship” fellowship

Zitieren

APA

Scala, R., Maqoud, F., McClenaghan, C., Harter, T. M., Perrone, M. G., Scilimati, A., Nichols, C. G., & Tricarico, D. (2023). Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome. Cells. https://doi.org/10.3390/cells12060928

Vancouver

Scala R, Maqoud F, McClenaghan C, Harter TM, Perrone MG, Scilimati A, et al. Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome. Cells. 2023. doi:10.3390/cells12060928

BibTeX
@article{Scala2023,
  author = {Scala, Rosa and Maqoud, Fatima and McClenaghan, Conor and Harter, Theresa M and Perrone, Maria Grazia and Scilimati, Antonio and Nichols, Colin G and Tricarico, Domenico},
  title = {Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12060928}
}
Kostenlos starten →